Why so little progress in therapeutic thrombolysis? The current state of the art and prospects for improvement-Reference-Cited by-同舟云学术

Why so little progress in therapeutic thrombolysis? The current state of the art and prospects for improvement

Published:2015-04-18 Issue:4 Volume:40 Page:480-487
ISSN:0929-5305
Container-title:Journal of Thrombosis and Thrombolysis
language:en
Short-container-title:J Thromb Thrombolysis

Author:

Gurewich Victor

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,Hematology

Link

http://link.springer.com/content/pdf/10.1007/s11239-015-1217-3.pdf

Reference56 articles.

1. ISTH Steering Committee for World Thrombosis Day (2014) Thrombosis: a major contributor to global disease burden. Thromb Hemost 12:843–852

2. Virchow R (1856) Thrombose und Embolie. Gefassentzundung und septische infektion. Gesammelte Abhandlungen zur Wissenschaftlichen Medicin (in German), vol 219. Von Meidinger & Sohn, Frankfurt am Main, p 732

3. Afilalo J, Roy AM, Eisenberg MJ (2009) Systematic review of fibrinolytic-facilitated percutaneous coronary intervention: potential benefits and future challenges. Can J Cardiol 25:141–148

4. Kleindorfer D, Lindsell CJ, Brass I, Koroschetz W, Broderick JP (2008) National US estimates of recombinant tissue plasminogen activator use: ICD-9 codes substantially underestimates. Stroke 39:924–928

5. Konstantinides SV (2014) Fibrinolysis for patients with intermediate-risk pulmonary embolism. N Engl J Med 370:1402–1411

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In silico study of combination thrombolytic therapy with alteplase and mutant pro-urokinase for fibrinolysis in ischemic stroke;Computers in Biology and Medicine;2024-03

2. Fibrinolytic Agents in Thromboembolic Diseases: Historical Perspectives and Approved Indications;Seminars in Thrombosis and Hemostasis;2024-03-01

3. Clot Lysis Activity of Bacillus subtilis G8 Isolated from Japanese Fermented Natto Soybeans;APPL FOOD BIOTECHNOL;2019

4. Structural Biology and Protein Engineering of Thrombolytics;Computational and Structural Biotechnology Journal;2019

5. Passivating Injured Endothelium with Kinexins in Thrombolytic Therapy;Thrombosis and Haemostasis;2018